The positive association of IDO with CXCL9 and with the COPD smokers with CXCL9 (Table 2) suggests a potential anti-inflammatory action in response to inflammation in the COPD smokers group. This evidence concerns the gene CXCL9 and chronic obstructive pulmonary disease.